Early molecular response ≤1% has strong prognostic impact...

  • Main
  • 2018 / 10
  • Early molecular response ≤1% has strong prognostic impact...
British Journal of Haematology 2018 / 10

Early molecular response ≤1% has strong prognostic impact for CML patients that switch to second-line therapy with BCR-ABL1 ≤10% and no major molecular response

Bonecker, Simone, Carvalho, Gabriela, Dobbin, Jane, Zalcberg, Ilana, Schaffel, Rony
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Language:
english
Journal:
British Journal of Haematology
DOI:
10.1111/bjh.15611
Date:
October, 2018
File:
PDF, 102 KB
english, 2018
Conversion to is in progress
Conversion to is failed